Chronic Subdural Haematoma

Subspecialty: Neurotrauma

Type: Clinical Summary

Chronic subdural hematoma (CSDH) is a liquefying collection of blood and blood-breakdown products in the subdural space driven by trauma-triggered inflammation, membrane formation and neovascularization; it is most common in older adults and carries substantial morbidity because of neurologic deficits and a 10–20% recurrence rate after evacuation. This summary synthesizes randomized control trial data from Dexamethasone use, contemporary meta-analyses of glucocorticoid therapy, and recent randomized-trial evidence and meta-analysis for Middle meningeal artery embolization (MMAE), focusing on m…

Source Papers

Middle meningeal artery embolization for chronic subdural hematoma: meta-analysis of three randomized controlled trials and review of ongoing trials. (2025)
Steroid in Chronic Subdural Hematoma: An Updated Systematic Review and Meta-Analysis Post DEX-CSDH Trial, (2022)
Trial of Dexamethasone for Chronic Subdural Hematoma (2020)